Newly Public AGA Medical Reports 15% Sales Growth In Third Quarter
This article was originally published in The Gray Sheet
Executive Summary
AGA Medical, maker of Amplatzer structural heart defect repair devices and vascular disease treatments, reported third-quarter sales growth of 14.9% to $50.2 million on Nov. 3 - two weeks after going public in a $200 million initial public offering